Joshua Cohen

Social justice advocate. Coffee drinker. Obsessive @spotify playlist maker. Husband. Father.

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications

Published Content

10
Increasing Numbers of Americans Want Single Payer, But Is That What They Want?
forbes.comArticle
Increasing Numbers of Americans Want Single Payer, But Is That What They Want?
August, 16 2018
Has Amyloid-Based Research Turned The Corner?
forbes.comArticle
Has Amyloid-Based Research Turned The Corner?
August, 13 2018
Better U.S. Patient Access To Cancer Drugs Comes At A Price
forbes.comArticle
Better U.S. Patient Access To Cancer Drugs Comes At A Price
August, 9 2018
Changes To Drug Prices: Gestures And Real Policy Shifts
forbes.comArticle
Changes To Drug Prices: Gestures And Real Policy Shifts
August, 7 2018
Taking A Wider View Of Precision Oncology
forbes.comArticle
Taking A Wider View Of Precision Oncology
August, 2 2018
Right To Try For Some Raises False Hopes For Many
forbes.comArticle
Right To Try For Some Raises False Hopes For Many
July, 27 2018
Precision Medicine Success Hinges On Diagnostics' Clinical Utility
forbes.comArticle
Precision Medicine Success Hinges On Diagnostics' Clinical Utility
July, 23 2018
'Diseases Of Despair' Contribute To Declining U.S. Life Expectancy
forbes.comArticle
'Diseases Of Despair' Contribute To Declining U.S. Life Expectancy
July, 19 2018
Bold Rx-To-OTC Switches On The Horizon? Naloxone, Perhaps
forbes.comArticle
Bold Rx-To-OTC Switches On The Horizon? Naloxone, Perhaps
July, 16 2018
Gradual Progress In Precision Non-Oncology, But Challenges Persist
forbes.comArticle
Gradual Progress In Precision Non-Oncology, But Challenges Persist
July, 10 2018
Authorship Stats
1Sites10Projects7,306Words
About
Joshua Cohen is a writer who has produced content for forbes.com
Key Phrases
Cancer Drugs, Single Payer, Companion Diagnostics, Precision Medicine, Clinical Utility, Drug Prices, Drug Administration, Amyloid Imaging, Companion Diagnostic, Precision Oncology
© ClearVoice, Inc.